SBIR-STTR Award

Piezoelectric Pipetting Technology for DNA Analysis
Award last edited on: 1/11/06

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$1,735,802
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Peter J Wiktor

Company Information

Engineering Arts LLC

P.O. Box 51120
Phoenix, AZ 85076
   (480) 626-5946
   pkahn@engineeringarts.com
   www.engineeringarts.com
Location: Single
Congr. District: 09
County: Maricopa

Phase I

Contract Number: 1R43CA083390-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2002
Phase I Amount
$150,000
The proposed research follows two distinct yet complementary paths. One path involves developing and testing novel piezoelectric pipetting, dispensing, sensing and housing technology and integrating this into a fully automated piezoelectric pipetting system. Innovative piezoelectric-based technology enables pipetting of sub-nanoliter volumes of fluid and continuous monitoring to detect clogged tips and other operational states. The other path involves doing cancer-related genomics research in collaborative studies with the Fred Hutchinson Cancer Research Center (F.H.C.R.C.) to use the proposed piezoelectric pipetting system to 1) develop more robust oligonucleotide or cDNA-based microarray platforms for gene expression analyses, 2) complete the development of a cDNA microarray-based platform for simultaneous genotyping and gene expression monitoring and 3) develop novel, high-throughput DNA microarray-based assays of cellular function that will make it possible to assay phenotypic effects of silencing specific genes on a genomic scale. On the one hand, the molecular-biology research provides a real-world application to help focus the design of the piezoelectric pipetting system and validate its performance. On the other hand, the system provides the enabling technology in terms of reliability, speed, experiment design flexibility, spot reproducibility and density to make the cancer genomics and functional genomics related research feasible. The ultimate goal of the proposed research is to have the two paths come together, resulting in a fully functional and tested general-purpose, automated, piezoelectric, fluid pipetting system with the reliability and performance to empower cancer related, genomic and functional genomics research

Phase II

Contract Number: 2R44CA083390-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2003
(last award dollars: 2005)
Phase II Amount
$1,585,802

The proposed research follows two distinct yet complementary paths. One path involves developing and testing novel piezoelectric pipetting, dispensing, sensing and housing technology and integrating this into a fully automated piezoelectric pipetting system. Innovative piezoelectric-based technology enables pipetting of sub-nanoliter volumes of fluid and continuous monitoring to detect clogged tips and other operational states. The other path involves doing cancer-related genomics research in collaborative studies with the Fred Hutchinson Cancer Research Center (F.H.C.R.C.) to use the proposed piezoelectric pipetting system to 1) develop more robust oligonucleotide or cDNA-based microarray platforms for gene expression analyses, 2) complete the development of a cDNA microarray-based platform for simultaneous genotyping and gene expression monitoring and 3) develop novel, high-throughput DNA microarray-based assays of cellular function that will make it possible to assay phenotypic effects of silencing specific genes on a genomic scale. On the one hand, the molecular-biology research provides a real-world application to help focus the design of the piezoelectric pipetting system and validate its performance. On the other hand, the system provides the enabling technology in terms of reliability, speed, experiment design flexibility, spot reproducibility and density to make the cancer genomics and functional genomics related research feasible. The ultimate goal of the proposed research is to have the two paths come together, resulting in a fully functional and tested general-purpose, automated, piezoelectric, fluid pipetting system with the reliability and performance to empower cancer related, genomic and functional genomics research